...
首页> 外文期刊>Quality of life research: An international journal of quality of life aspects of treatment, care and rehabilitation >Post-treatment Lyme disease syndrome symptomatology and the impact on life functioning: Is there something here?
【24h】

Post-treatment Lyme disease syndrome symptomatology and the impact on life functioning: Is there something here?

机译:治疗后的莱姆病综合征的症状及其对生命机能的影响:这里有事吗?

获取原文
获取原文并翻译 | 示例
           

摘要

Purpose: A subset of patients treated for Lyme disease report persistent or recurrent symptoms of unknown etiology named post-treatment Lyme disease syndrome (PTLDS). This study aims to describe a cohort of participants with early, untreated Lyme disease, and characterize post-treatment symptomatology and functional impact of PTLDS over time. Methods: Sixty-three participants with erythema migrans and systemic symptoms were enrolled in a prospective cohort study. Participants underwent physical exams and clinical assessments, and completed the SF-36 (daily life functioning) and the Beck Depression Inventory, Second Edition (BDI-II) (depression), at each of five visits over a period of 6 months. Results: Signs of Lyme disease disappeared post-treatment; however, new-onset patient-reported symptoms increased or plateaued over time. At 6 months, 36% of patients reported new-onset fatigue, 20% widespread pain, and 45% neurocognitive difficulties. However, less than 10% reported greater than "minimal" depression across the entire period. Those with PTLDS (36%) did not differ significantly from those without with respect to demographics, pre-treatment SF-36, and BDI-II scores. Statistically significant differences were found over time on the Role Physical, Vitality, Social Functioning, Role Emotional, and Mental Health subscales (with a trend toward significance for the remaining three subscales of Physical Functioning, Bodily Pain, and General Health) of the SF-36 between those with an eventual PTLDS diagnosis and those without when measured at 6 months. Conclusions: Unlike clinical signs of Lyme disease, new-onset symptoms are reported by a subset of participants without evidence of depressive symptomatology. Patients who developed PTLDS had significantly lower life functioning compared to those without PTLDS. We propose future avenues for researching infection-triggered symptoms resulting from multiple mechanisms. ? 2012 The Author(s).
机译:目的:治疗莱姆病的一部分患者报告病因不明的持续或复发症状,称为治疗后莱姆病综合征(PTLDS)。这项研究旨在描述一群未经治疗的早期莱姆病的参与者,并描述随着时间推移PTLDS的治疗后症状和功能影响。方法:将63名患有红斑偏头痛和系统症状的参与者纳入一项前瞻性队列研究。参加者进行了身体检查和临床评估,并在6个月内进行了五次访问,分别完成了SF-36(日常生活功能)和贝克抑郁量表第二版(BDI-II)(抑郁)。结果:治疗后莱姆病的症状消失了;然而,随着时间的流逝,新患者报告的症状增加或趋于平稳。在6个月时,有36%的患者报告了新发作的疲劳,20%的广泛疼痛和45%的神经认知障碍。但是,少于10%的人报告在整个时期内抑郁症的程度大于“最小”程度。那些拥有PTLDS的人(36%)与那些没有人口统计学,治疗前SF-36和BDI-II评分的人没有显着差异。随着时间的流逝,SF-最终诊断为PTLDS的患者与没有进行6个月测量的患者之间的差异为36。结论:与莱姆病的临床体征不同,一部分参与者报告了新发症状,而没有抑郁症状的证据。与没有PTLDS的患者相比,患有PTLDS的患者的生活功能显着降低。我们提出了研究多种机制引起的感染触发症状的未来途径。 ? 2012作者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号